Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Reply letter to: Emergency general surgery - is there any value in a '100 most cited' list?

Powell AGMT, Ellul T, Bullock N, Lewis WG.

Int J Surg. 2019 Feb 10. pii: S1743-9191(19)30033-0. doi: 10.1016/j.ijsu.2019.02.003. [Epub ahead of print] No abstract available.

PMID:
30753893
2.

Fit for Cancer Treatment: a prospective feasibility study of primary care initiated prehabilitation for patients with suspected cancer.

Barlow RC, Chan DSY, Mayor S, Perkins C, Lawton HL, Powell AG, Lewis WG.

BJGP Open. 2018 Oct 17;2(4):bjgpopen18X101608. doi: 10.3399/bjgpopen18X101608. eCollection 2018 Dec.

3.

Src family kinases, HCK and FGR, associate with local inflammation and tumour progression in colorectal cancer.

Roseweir AK, Powell AGMT, Horstman SL, Inthagard J, Park JH, McMillan DC, Horgan PG, Edwards J.

Cell Signal. 2019 Apr;56:15-22. doi: 10.1016/j.cellsig.2019.01.007. Epub 2019 Jan 23.

PMID:
30684564
4.

Relative Value of Adapted Novel Bibliometrics in Evaluating Surgical Academic Impact and Reach.

Robinson DBT, Hopkins L, Brown C, Abdelrahman T, Powell AG, Egan RJ, Lewis WG.

World J Surg. 2019 Apr;43(4):967-972. doi: 10.1007/s00268-018-04893-w.

PMID:
30564922
5.

Propensity score analysis of 18-FDG PET/CT-enhanced staging in patients undergoing surgery for esophageal cancer.

Patel N, Foley KG, Powell AG, Wheat JR, Chan D, Fielding P, Roberts SA, Lewis WG.

Eur J Nucl Med Mol Imaging. 2018 Aug 16. doi: 10.1007/s00259-018-4118-9. [Epub ahead of print]

PMID:
30116837
6.

A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with Stage II/III colorectal cancer.

Roseweir AK, Kong CY, Park JH, Bennett L, Powell AGMT, Quinn J, van Wyk HC, Horgan PG, McMillan DC, Edwards J, Roxburgh CS.

Int J Cancer. 2019 Jan 1;144(1):150-159. doi: 10.1002/ijc.31739. Epub 2018 Oct 30.

PMID:
29992570
7.

ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer.

Roseweir AK, Halcrow ES, Chichilo S, Powell AG, McMillan DC, Horgan PG, Edwards J.

Br J Cancer. 2018 Aug;119(3):323-329. doi: 10.1038/s41416-018-0174-y. Epub 2018 Jul 10.

PMID:
29988110
8.

Systematic Review and Meta-Analysis of the Prognostic Significance of Neutrophil-Lymphocyte Ratio (NLR) After R0 Gastrectomy for Cancer.

Mellor KL, Powell AGMT, Lewis WG.

J Gastrointest Cancer. 2018 Sep;49(3):237-244. doi: 10.1007/s12029-018-0127-y. Review.

9.

Mode of presentation rather than the 'weekend effect' is a major determinant of in-hospital mortality.

Williams A, Powell AGMT, Spernaes I, Basu P, Edwards S, Edwards P.

Surgeon. 2019 Feb;17(1):15-18. doi: 10.1016/j.surge.2018.04.007. Epub 2018 May 31.

PMID:
29861144
10.

Altmetric Versus Bibliometric Perspective Regarding Publication Impact and Force.

Powell AGMT, Bevan V, Brown C, Lewis WG.

World J Surg. 2018 Sep;42(9):2745-2756. doi: 10.1007/s00268-018-4579-9.

11.

Laparoscopic Surgery's 100 Most Influential Manuscripts: A Bibliometric Analysis.

Mellor KL, Powell AGMT, Lewis WG.

Surg Laparosc Endosc Percutan Tech. 2018 Feb;28(1):13-19. doi: 10.1097/SLE.0000000000000507. Review.

PMID:
29356732
12.

Meta-analysis of the prognostic value of CpG island methylator phenotype in gastric cancer.

Powell AGMT, Soul S, Christian A, Lewis WG.

Br J Surg. 2018 Jan;105(2):e61-e68. doi: 10.1002/bjs.10742. Review.

PMID:
29341152
13.

Prognostic Significance of Serum Inflammatory Markers in Gastric Cancer.

Powell AGMT, Parkinson D, Patel N, Chan D, Christian A, Lewis WG.

J Gastrointest Surg. 2018 Apr;22(4):595-605. doi: 10.1007/s11605-017-3597-5. Epub 2017 Oct 4.

14.

Esophageal cancer's 100 most influential manuscripts: a bibliometric analysis.

Powell AG, Hughes DL, Brown J, Larsen M, Witherspoon J, Lewis WG.

Dis Esophagus. 2017 Apr 1;30(4):1-8. doi: 10.1093/dote/dow039.

PMID:
28375483
15.

The 100 most cited manuscripts in emergency abdominal surgery: A bibliometric analysis.

Ellul T, Bullock N, Abdelrahman T, Powell AG, Witherspoon J, Lewis WG.

Int J Surg. 2017 Jan;37:29-35. doi: 10.1016/j.ijsu.2016.12.006. Epub 2016 Dec 5.

16.

The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer.

Dreyer SB, Powell AG, McSorley ST, Waterston A, Going JJ, Edwards J, McMillan DC, Horgan PG.

Ann Surg Oncol. 2017 May;24(5):1295-1303. doi: 10.1245/s10434-016-5684-3. Epub 2016 Nov 21.

17.

Relationship between tumour PTEN/Akt/COX-2 expression, inflammatory response and survival in patients with colorectal cancer.

Roseweir AK, Powell AG, Bennett L, Van Wyk HC, Park J, McMillan DC, Horgan PG, Edwards J.

Oncotarget. 2016 Oct 25;7(43):70601-70612. doi: 10.18632/oncotarget.12134.

18.

Surgical Education's 100 Most Cited Articles: A Bibliometric Analysis.

Matthews AH, Abdelrahman T, Powell AG, Lewis WG.

J Surg Educ. 2016 Sep-Oct;73(5):919-29. doi: 10.1016/j.jsurg.2016.05.011. Epub 2016 Jun 22.

PMID:
27344302
19.

Long-Term Follow-Up of Patients Undergoing Resection of TNM Stage I Colorectal Cancer: An Analysis of Tumour and Host Determinants of Outcome.

Mansouri D, Powell AG, Park JH, McMillan DC, Horgan PG.

World J Surg. 2016 Jun;40(6):1485-91. doi: 10.1007/s00268-016-3443-z.

PMID:
26920405
20.

The 100 most influential manuscripts in gastric cancer: A bibliometric analysis.

Powell AG, Hughes DL, Wheat JR, Lewis WG.

Int J Surg. 2016 Apr;28:83-90. doi: 10.1016/j.ijsu.2016.02.028. Epub 2016 Feb 10. Review.

21.

Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment.

Park JH, Powell AG, Roxburgh CS, Horgan PG, McMillan DC, Edwards J.

Br J Cancer. 2016 Mar 1;114(5):562-70. doi: 10.1038/bjc.2016.17. Epub 2016 Feb 9.

22.

Evaluation of a tumor microenvironment-based prognostic score in primary operable colorectal cancer.

Park JH, McMillan DC, Powell AG, Richards CH, Horgan PG, Edwards J, Roxburgh CS.

Clin Cancer Res. 2015 Feb 15;21(4):882-8. doi: 10.1158/1078-0432.CCR-14-1686. Epub 2014 Dec 3.

23.
24.

The clinical utility of the local inflammatory response in colorectal cancer.

Richards CH, Roxburgh CS, Powell AG, Foulis AK, Horgan PG, McMillan DC.

Eur J Cancer. 2014 Jan;50(2):309-19. doi: 10.1016/j.ejca.2013.09.008. Epub 2013 Oct 5.

PMID:
24103145
25.

The relationship between genetic profiling, clinicopathological factors and survival in patients undergoing surgery for node-negative colorectal cancer: 10-year follow-up.

Powell AG, Ferguson J, Al-Mulla F, Orange C, McMillan DC, Horgan PG, Edwards J, Going JJ.

J Cancer Res Clin Oncol. 2013 Dec;139(12):2013-20. doi: 10.1007/s00432-013-1521-2. Epub 2013 Sep 26.

PMID:
24072233
26.

The in situ local immune response, tumour senescence and proliferation in colorectal cancer.

Roxburgh CS, Richards CH, Macdonald AI, Powell AG, McGlynn LM, McMillan DC, Horgan PG, Edwards J, Shiels PG.

Br J Cancer. 2013 Oct 15;109(8):2207-16. doi: 10.1038/bjc.2013.556. Epub 2013 Sep 10.

27.

Time to assess alternatives to hydroxyethyl starch to use instead of 0.9% saline in fluid replacement.

Cruickshanks M, Drummond GB, Paterson-Brown S, Powell AG.

BMJ. 2013 Jul 30;347:f4651. doi: 10.1136/bmj.f4651. No abstract available.

PMID:
23900815
28.

The relationship between tumour site, clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer.

Powell AG, Wallace R, McKee RF, Anderson JH, Going JJ, Edwards J, Horgan PG.

Colorectal Dis. 2012 Dec;14(12):1493-9. doi: 10.1111/j.1463-1318.2012.03048.x.

PMID:
22507826
29.

The bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key?

Powell AG, Horgan PG, Edwards J.

J Cancer Res Clin Oncol. 2012 May;138(5):723-8. doi: 10.1007/s00432-012-1192-4. Epub 2012 Mar 18. Review.

PMID:
22426959
30.

Advances in medical therapy for weight loss and the weight-centric management of type 2 diabetes mellitus.

Igel LI, Powell AG, Apovian CM, Aronne LJ.

Curr Atheroscler Rep. 2012 Feb;14(1):60-9. doi: 10.1007/s11883-011-0221-0. Review.

PMID:
22113707
31.

The combination of phentermine and topiramate is an effective adjunct to diet and lifestyle modification for weight loss and measures of comorbidity in overweight or obese adults with additional metabolic risk factors.

Powell AG, Apovian CM, Aronne LJ.

Evid Based Med. 2012 Feb;17(1):14-5. doi: 10.1136/ebm.2011.100103. Epub 2011 Sep 21. No abstract available.

PMID:
21937501
32.

A move towards individualization of patient treatment regimens in colorectal cancer.

Powell AG, Edwards J, Horgan PG.

Colorectal Dis. 2012 Feb;14(2):255-6. doi: 10.1111/j.1463-1318.2011.02818.x. No abstract available.

PMID:
21910813
33.

Emerging pharmacotherapy for obesity.

Aronne LJ, Powell AG, Apovian CM.

Expert Opin Emerg Drugs. 2011 Sep;16(3):587-96. doi: 10.1517/14728214.2011.609168. Epub 2011 Aug 12. Review.

PMID:
21834735
34.

New drug targets for the treatment of obesity.

Powell AG, Apovian CM, Aronne LJ.

Clin Pharmacol Ther. 2011 Jul;90(1):40-51. doi: 10.1038/clpt.2011.82. Epub 2011 Jun 8. Review.

PMID:
21654742
35.

Safety through education. FY1 doctors still poor in prescribing intravenous fluids.

Powell AG, Paterson-Brown S.

BMJ. 2011 May 17;342:d2741. doi: 10.1136/bmj.d2741. No abstract available.

PMID:
21586458
36.

A case of septicaemic anthrax in an intravenous drug user.

Powell AG, Crozier JE, Hodgson H, Galloway DJ.

BMC Infect Dis. 2011 Jan 20;11:21. doi: 10.1186/1471-2334-11-21.

Supplemental Content

Loading ...
Support Center